Inventor · disambiguated record
Joan Seoane Suarez
Also filed as: SEOANE SUAREZ JOAN · SEOANE SUÁREZ JOAN
5 granted patents·10 pending applications·15 citations·filing 2010–2024
75Inventor score
Files withMEDIMMUNE LTD7FUNDACIO PRIVADA INST CATALANA DE RECERCA I ESTUDIS AVANCATS ICREA3SEOANE SUAREZ JOAN2FUNDACIO PRIVADA INST DINVESTIGACIO ONCOLOGICA DE VALL HEBRON1FUNDACIO PRIVADA INST DINVESTIGACIO ONCOLOGICA DE VALL HEBROON1
Top patents by PatentIndex Score
15 records- 0182US11390670B2Antibodies against LIF and uses thereofMEDIMMUNE LTD·Filed 2017·Granted Jul 19, 2022·3 cites·16 claims
- 0281US10583191B2Antibodies against LIF and uses thereofMOSAIC BIOMEDICALS SLU·Filed 2017·Granted Mar 10, 2020·6 cites·16 claims
- 0375US8926956B2Antibody recognizing human leukemia inhibitory factor (LIF)SEOANE SUAREZ JOAN·Filed 2011·Granted Jan 6, 2015·5 cites·10 claims
- 0475US2024400667A1Therapeutic agents for the treatment of diseases associated with undesired cell proliferationFUNDACIO PRIVADA INST CATALANA DE RECERCA I ESTUDIS AVANCATS ICREA·Filed 2024·Application pending·0 cites
- 0563US2022323478A1Agents for the treatment of diseases associated with undesired cell proliferationFUNDACIO PRIVADA INST DINVESTIGACIO ONCOLOGICA DE VALL HEBROON·Filed 2022·Application pending·0 cites
- 0662US10100112B2Therapeutic agents for the treatment of diseases associated with undesired cell proliferationSEOANE SUAREZ JOAN·Filed 2010·Granted Oct 16, 2018·1 cites·10 claims
- 0762US2023042095A1Antibodies against lif and uses thereofMEDIMMUNE LTD·Filed 2022·Application pending·0 cites
- 0861US11999782B2Therapeutic agents for the treatment of diseases associated with undesired cell proliferationFUNDACIO PRIVADA INST CATALANA DE RECERCA I ESTUDIS AVANCATS ICREA·Filed 2020·Granted Jun 4, 2024·0 cites·3 claims
- 0948US2018344759A1Agents for the treatment of diseases associated with undesired cell proliferationFUNDACIO PRIVADA INST DINVESTIGACIO ONCOLOGICA DE VALL HEBRON·Filed 2016·Application pending·0 cites
- 1047US2019211095A1Therapeutic agents for the treatment of diseases associated with undesired cell proliferationFUNDACIO PRIVADA INST CATALANA DE RECERCA I ESTUDIS AVANCATS ICREA·Filed 2018·Application pending·0 cites
- 1146US2022064279A1Antibodies against lif and dosage forms thereofMEDIMMUNE LTD·Filed 2019·Application pending·0 cites
- 1243US2021130453A1Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancerMEDIMMUNE LTD·Filed 2019·Application pending·0 cites
- 1341US2021187106A1Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancerMEDIMMUNE LTD·Filed 2019·Application pending·0 cites
- 1440US2021253691A1Methods for improving response to anti-lif antibody treatment in individuals with cancerMEDIMMUNE LTD·Filed 2019·Application pending·0 cites
- 1540US2021190798A1Methods of quantifying lif and uses thereofMEDIMMUNE LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joan Seoane Suarez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →